共 20 条
- [1] C-Terminal-Truncating ASXL1 Mutations Induce MDS Via Inhibition Of PRC2BLOOD, 2013, 122 (21)Inoue, DaichiKitaura, JiroTogami, KatsuhiroNishimura, KoutarouEnomoto, YutakaUchida, TomoyukiKagiyama, YukiKawabata, Kimihito CojinNakahara, FumioOki, ToshihikoHarada, HironoriOchiya, TakahiroAburatani, HiroyukiKimura, HiroshiThol, FelicitasHeuser, MichaelLevine, Ross L.Abdel-Wahab, OmarKitamura, Toshio
- [2] ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene RepressionCANCER CELL, 2012, 22 (02) : 180 - 193Abdel-Wahab, OmarAdli, MazharLaFave, Lindsay M.Gao, JieHricik, ToddShih, Alan H.Pandey, SuvegPatel, Jay P.Chung, Young RockKoche, RichardPerna, FabianaZhao, XinyangTaylor, Jordan E.Park, Christopher Y.Carroll, MartinMelnick, AriNimer, Stephen D.Jaffe, Jacob D.Aifantis, IannisBernstein, Bradley E.Levine, Ross L.
- [3] ASXL1 Mutations Promote Myeloid Transformation Through Inhibition of PRC2-Mediated Gene RepressionBLOOD, 2011, 118 (21) : 185 - 186Abdel-Wahab, OmarAdli, MazharSaunders, LindsayGao, JieShih, Alan H.Pandey, SuvegJaffe, JakeZhao, XinyangPerna, FabianaCarroll, MartinMelnick, AriNimer, Stephen D.Aifantis, IannisBernstein, BradleyLevine, Ross L.
- [4] ASXL1 mutation induces MDS with derepression of p16Ink4a via aberrant histone modification by PRC1CANCER SCIENCE, 2018, 109 : 511 - 511Uni, MasahiroMasamoto, YosukeSato, TomohikoArai, ShunyaKurokawa, Mineo
- [5] Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasmsEXPERIMENTAL HEMATOLOGY, 2024, 132Collinsa, Taylor B.Laranjeiraa, Angelo B. A.Konga, TimFulbrighta, Mary C.Fishera, Daniel A. C.Sturgeona, Christopher M.Batistaa, Luis F. Z.Oh, Stephen T.
- [6] Similarities and Differences of DNMT3A, TET2 and ASXL1 Mutations across Ccus, MDS and AMLBLOOD, 2024, 144 : 1820 - 1820Huber, SandraHutter, StephanBaer, Constance ReginaMeggendorfer, ManjaHoermann, GregorKern, WolfgangHaferlach, TorstenHaferlach, Claudia
- [7] Myelodysplastic Syndromes (MDS) with 20q Deletion frequently show mutations in U2AF1, SRSF2 and ASXL1ONKOLOGIE, 2013, 36 : 125 - 125Bacher, U.Haferlach, T.Schnittger, S.Zenger, M.Grossmann, VRoller, A.Meggendorfer, M.Jeromin, S.Krauth, M-TAlpermann, T.Kern, W.Haferlach, C.
- [8] LINE1 and PRC2 control nucleolar organization and repression of the 8C state in human ESCsDEVELOPMENTAL CELL, 2025, 60 (02)Zhang, JuanAtaei, LamisaMittal, KirtiWu, LiangCaldwell, LaurenHuynh, LinhSarajideen, ShahilTse, KevinSimon, Marie-MichelleMazid, Md. AbdulCook, David P.Trcka, DanielKwan, TonyHoffman, Michael M.Wrana, Jeffrey L.Esteban, Miguel A.Ramalho-Santos, Miguel
- [9] Asxl1 exerts an antiproliferative effect on mouse lung maturation via epigenetic repression of the E2f1-Nmyc axisCELL DEATH & DISEASE, 2018, 9Moon, SeungtaeIm, Sun-KyoungKim, NackhyoungYoun, HyesookPark, Ui-HyunKim, Joo-YeonKim, A. -ReumAn, So-JungKim, Ji-HoonSun, WoongHwang, Jin-TaekKim, Eun-JooUm, Soo-Jong
- [10] Asxl1 exerts an antiproliferative effect on mouse lung maturation via epigenetic repression of the E2f1-Nmyc axisCell Death & Disease, 9Seungtae MoonSun-Kyoung ImNackhyoung KimHyesook YounUi-Hyun ParkJoo-Yeon KimA.-Reum KimSo-Jung AnJi-Hoon KimWoong SunJin-Taek HwangEun-Joo KimSoo-Jong Um